Mankind Pharma Limited (MANKIND.NS)
INR 2350.5
(1.58%)
INR 2350.5
(1.58%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.74 Billion INR | -30.04% |
| 2022 | -1.34 Billion INR | -123.57% |
| 2021 | 5.7 Billion INR | 676.49% |
| 2020 | 734.77 Million INR | 177.19% |
| 2019 | -951.93 Million INR | -161.88% |
| 2018 | 1.53 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 33.86 Billion INR | 2036.97% |
| 2023 Q3 | 23.25 Billion INR | 3240.91% |
| 2023 Q2 | -740.51 Million INR | -104.84% |
| 2023 Q1 | 15.28 Billion INR | 1236.98% |
| 2023 Q4 | -1.74 Billion INR | -107.52% |
| 2023 FY | -1.74 Billion INR | -30.04% |
| 2022 Q4 | -1.34 Billion INR | 27.82% |
| 2022 FY | -1.34 Billion INR | -123.57% |
| 2022 Q3 | -1.86 Billion INR | 0.0% |
| 2021 Q4 | 5.7 Billion INR | 0.0% |
| 2021 FY | 5.7 Billion INR | 676.49% |
| 2020 FY | 734.77 Million INR | 177.19% |
| 2019 FY | -951.93 Million INR | -161.88% |
| 2018 FY | 1.53 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 145.225% |
| Hester Biosciences Limited | 2.29 Billion INR | 176.323% |
| Aarti Drugs Limited | 5.54 Billion INR | 131.511% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 166.938% |
| Albert David Limited | -278.36 Million INR | -528.07% |
| Alembic Limited | 66.9 Million INR | 2713.38% |
| Alkem Laboratories Limited | -1.6 Billion INR | -8.634% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | 860.374% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 152.997% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -9378.212% |
| Brooks Laboratories Limited | 49.48 Million INR | 3633.093% |
| Eris Lifesciences Limited | 13.8 Billion INR | 112.663% |
| FDC Limited | -57.75 Million INR | -2927.343% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 38.496% |
| Gufic Biosciences Limited | 3.19 Billion INR | 154.733% |
| Hikal Limited | 7.96 Billion INR | 121.945% |
| Ind-Swift Limited | 9.5 Billion INR | 118.387% |
| Innova Captab Limited | 2.33 Billion INR | 174.916% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | -58.753% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | -25.787% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 106.458% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | -1269.773% |
| Lupin Limited | 19.38 Billion INR | 109.019% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 279.169% |
| Medico Remedies Limited | 78.67 Million INR | 2322.188% |
| Morepen Laboratories Limited | -231.17 Million INR | -656.292% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 128.395% |
| Orchid Pharma Limited | -1.31 Billion INR | -33.071% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 25.539% |
| RPG Life Sciences Limited | -364.7 Million INR | -379.394% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 1556.486% |
| Sigachi Industries Limited | 859.94 Million INR | 303.309% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 117.428% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 1305.959% |
| Themis Medicare Limited | 764.96 Million INR | 328.554% |
| Unichem Laboratories Limited | 931.91 Million INR | 287.608% |
| Vaishali Pharma Limited | 119.13 Million INR | 1567.538% |
| Wanbury Limited | 1.1 Billion INR | 258.097% |
| Windlas Biotech Limited | -273.04 Million INR | -540.328% |
| ZIM Laboratories Limited | 983.6 Million INR | 277.749% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 57.902% |
| Ipca Laboratories Limited | 11.41 Billion INR | 115.316% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 97.587% |
| Venus Remedies Limited | -267.7 Million INR | -553.101% |
| Sakar Healthcare Limited | 790.93 Million INR | 321.048% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 147.338% |
| Divi's Laboratories Limited | -39.77 Billion INR | 95.604% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 65.12% |
| Sequent Scientific Limited | 4.17 Billion INR | 141.84% |
| Laurus Labs Limited | 24.35 Billion INR | 107.178% |
| Neuland Laboratories Limited | -214.05 Million INR | -716.765% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 161.972% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 59.201% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 144.692% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -602.736% |
| Wockhardt Limited | 18.27 Billion INR | 109.57% |
| Bal Pharma Limited | 1.26 Billion INR | 238.367% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 113.539% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | -51.013% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | -376.989% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 68.256% |
| Shilpa Medicare Limited | 9.06 Billion INR | 119.277% |
| Valiant Laboratories Limited | 649.9 Million INR | 369.018% |
| Ajanta Pharma Limited | -954.9 Million INR | -83.093% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | 687.524% |
| Granules India Limited | 9.28 Billion INR | 118.826% |
| Medicamen Biotech Limited | 160.31 Million INR | 1190.566% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 3883.409% |
| Piramal Enterprises Limited | 491.39 Billion INR | 100.356% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 105.493% |
| NATCO Pharma Limited | -5.81 Billion INR | 69.944% |
| Suven Life Sciences Limited | -1.63 Billion INR | -7.084% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 190.451% |
| Strides Pharma Science Limited | 23.25 Billion INR | 107.518% |
| Indoco Remedies Limited | 6.47 Billion INR | 126.996% |
| Alpa Laboratories Limited | 35.36 Million INR | 5044.012% |
| Lasa Supergenerics Limited | 205.79 Million INR | 949.543% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | -85.639% |